Solid Biosciences

Solid Biosciences

SLDB· Manufacturing· Fiscal year ends in December

CEO pay in FY2025Stock +41.0% in FY2025

Alexander Cumbo is the CEO of Solid Biosciences and was paid $5.2M in FY2025 (Dec), up 7%.

Pay$100 in the stock at the end of FY21 → $19
CEO pay is from each Solid Biosciences proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Executives3

See all
  1. 1Alexander CumboFY2025
  2. 2David Tyronne HowtonFY2025
  3. 3Gabriel Brooks, M.D.FY2025

Named executives and their total pay, from the Summary Compensation Table of the latest proxy.

Pay

See all

Solid Biosciences paid its 3 named executives $10.1M in total in FY2025 (Dec). CEO Alexander Cumbo was paid $5.2M of that.

Name
Alexander CumboPresident and Chief Executive OfficerNot disclosed
David Tyronne HowtonChief Operating Officer and Secretary
Gabriel Brooks, M.D.Chief Medical OfficerNot disclosed

of each named executive, from the Summary Compensation Table of each proxy.

Peers

No disclosed peer group

No proxy on file names a pay peer group for Solid Biosciences. The peer group comes from the proxy statement, so it shows here when a proxy read has it.

Activity

Filings6

See all
Proxy statementDEF 14AApr 23, 2026FY2025
Annual report10-KMar 19, 2026FY2025
Proxy statementDEF 14AApr 25, 2025FY2024
Annual report10-KMar 6, 2025FY2024
Proxy statementDEF 14AApr 26, 2024FY2023
Annual report10-KMar 13, 2024FY2023
For the press:Download CSVDownload PNGHow to use our data